Astrazeneca plc ADR (AZN) Volatility Spurs A Quest For Clarity
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of -0.21% and -0.13% over the past three months. AZN shares are trading 3.59% year to date (YTD), with the 12-month market performance down to -0.72% lower. […]
Astrazeneca plc ADR (AZN): A Great Stock For Handling Current Market Conditions?
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 4.58% and 3.82% over the past three months. AZN shares are trading 3.59% year to date (YTD), with the 12-month market performance down to -1.54% lower. […]
Handle With Care: Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of -10.49% and -0.69% over the past three months. AZN shares are trading 0.41% year to date (YTD), with the 12-month market performance down to -2.30% lower. […]
Are Analysts Expecting A Better 2020 For Astrazeneca plc ADR (AZN)?
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $72.22, with 4.17 million shares of worth about $301.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.30% during that period and on April 03, 2025 the price saw a […]
Astrazeneca plc ADR (AZN) Volatility Spurs A Quest For Clarity
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of -5.22% and 13.36% over the past three months. AZN shares are trading 11.49% year to date (YTD), with the 12-month market performance up to 10.36% higher. […]
Astrazeneca plc ADR (NASDAQ: AZN) Stock In Prove Me State
Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $76.32, with 4.05 million shares of worth about $309.12 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.44% during that period and on Wednesday the price saw a loss of […]
Astrazeneca plc ADR (NASDAQ: AZN): Hunting Genuine Value In Market Debris
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. The company’s stock has a 5-day price change of 5.91% and 1.94% over the past three months. AZN shares are trading -3.43% year to date (YTD), with the 12-month market performance down to -4.28% lower. […]
Analyst Expect Big Moves From Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. However, the script later moved the day high at 63.37, down -1.98%. The company’s stock has a 5-day price change of -5.15% and -2.00% over the past three months. AZN shares are trading -7.56% year […]
Handle With Care: Astrazeneca plc ADR (NASDAQ: AZN)
Currently, there are 3.10B common shares owned by the public and among those 3.10B shares have been available to trade. However, the script later moved the day high at 65.64, down -0.76%. The company’s stock has a 5-day price change of -3.05% and 1.50% over the past three months. AZN shares are trading -3.28% year […]
Astrazeneca plc ADR (AZN): Insights At A Glance
Astrazeneca plc ADR (AZN) concluded trading on Thursday at a closing price of $66.85, with 4.47 million shares of worth about $298.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.14% during that period and on Thursday, February 01 price saw a gain […]
